Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Health Expenditures | 83 | 2024 | 2363 | 8.000 |
Why?
|
Cost Sharing | 38 | 2024 | 409 | 6.900 |
Why?
|
Medicare | 85 | 2024 | 6774 | 6.310 |
Why?
|
Insurance, Health | 43 | 2021 | 2495 | 4.270 |
Why?
|
Cost Savings | 33 | 2023 | 912 | 4.240 |
Why?
|
Health Benefit Plans, Employee | 18 | 2021 | 332 | 3.950 |
Why?
|
Medicare Part C | 12 | 2024 | 330 | 3.280 |
Why?
|
Blue Cross Blue Shield Insurance Plans | 15 | 2019 | 92 | 3.020 |
Why?
|
Economic Competition | 10 | 2024 | 219 | 2.980 |
Why?
|
Fee-for-Service Plans | 22 | 2024 | 697 | 2.950 |
Why?
|
Reimbursement Mechanisms | 18 | 2024 | 667 | 2.740 |
Why?
|
Managed Care Programs | 15 | 2018 | 937 | 2.570 |
Why?
|
Health Care Reform | 18 | 2018 | 1247 | 2.530 |
Why?
|
Reimbursement, Incentive | 19 | 2022 | 542 | 2.480 |
Why?
|
Quality of Health Care | 29 | 2024 | 4325 | 2.100 |
Why?
|
United States | 179 | 2024 | 72292 | 2.060 |
Why?
|
Budgets | 6 | 2018 | 230 | 2.040 |
Why?
|
Commerce | 16 | 2023 | 608 | 1.960 |
Why?
|
Cost Control | 22 | 2020 | 627 | 1.850 |
Why?
|
Health Services | 9 | 2023 | 751 | 1.750 |
Why?
|
Health Care Costs | 20 | 2021 | 3238 | 1.690 |
Why?
|
Insurance Carriers | 6 | 2024 | 155 | 1.600 |
Why?
|
Group Practice | 6 | 2021 | 151 | 1.550 |
Why?
|
Deductibles and Coinsurance | 8 | 2019 | 316 | 1.530 |
Why?
|
Delivery of Health Care | 23 | 2023 | 5334 | 1.510 |
Why?
|
Patient Protection and Affordable Care Act | 16 | 2020 | 1187 | 1.450 |
Why?
|
Health Care Sector | 3 | 2021 | 195 | 1.400 |
Why?
|
Physicians | 15 | 2024 | 4583 | 1.330 |
Why?
|
Benchmarking | 8 | 2023 | 1045 | 1.290 |
Why?
|
Health Maintenance Organizations | 10 | 2012 | 658 | 1.260 |
Why?
|
Financing, Personal | 7 | 2016 | 308 | 1.210 |
Why?
|
Economics, Hospital | 4 | 2023 | 210 | 1.190 |
Why?
|
Hospitals, Rural | 3 | 2024 | 176 | 1.160 |
Why?
|
Private Sector | 7 | 2020 | 394 | 1.140 |
Why?
|
Medicaid | 11 | 2020 | 2814 | 1.130 |
Why?
|
Models, Economic | 10 | 2022 | 714 | 1.110 |
Why?
|
Fee Schedules | 3 | 2024 | 87 | 1.060 |
Why?
|
Physicians, Primary Care | 5 | 2021 | 618 | 1.050 |
Why?
|
Prospective Payment System | 2 | 2021 | 135 | 1.020 |
Why?
|
Health Facility Merger | 2 | 2023 | 47 | 0.960 |
Why?
|
Personnel Turnover | 3 | 2020 | 88 | 0.920 |
Why?
|
Health Facility Closure | 1 | 2023 | 24 | 0.860 |
Why?
|
Medicare Part D | 6 | 2014 | 354 | 0.840 |
Why?
|
Quality Assurance, Health Care | 6 | 2018 | 2164 | 0.830 |
Why?
|
Medication Adherence | 9 | 2024 | 2175 | 0.800 |
Why?
|
Costs and Cost Analysis | 10 | 2021 | 1663 | 0.780 |
Why?
|
Insurance Coverage | 14 | 2019 | 1937 | 0.770 |
Why?
|
Financial Management, Hospital | 2 | 2018 | 70 | 0.760 |
Why?
|
Hypoglycemic Agents | 5 | 2019 | 3085 | 0.760 |
Why?
|
Quality Indicators, Health Care | 10 | 2019 | 1790 | 0.730 |
Why?
|
Public Sector | 2 | 2014 | 264 | 0.720 |
Why?
|
Skilled Nursing Facilities | 2 | 2024 | 399 | 0.710 |
Why?
|
Insurance, Health, Reimbursement | 3 | 2018 | 385 | 0.700 |
Why?
|
Practice Management, Medical | 1 | 2021 | 191 | 0.680 |
Why?
|
Humans | 198 | 2024 | 760740 | 0.660 |
Why?
|
Patient Care | 4 | 2020 | 621 | 0.650 |
Why?
|
Hospitals | 8 | 2024 | 3879 | 0.650 |
Why?
|
Hospital Costs | 3 | 2021 | 947 | 0.650 |
Why?
|
Efficiency, Organizational | 8 | 2017 | 695 | 0.620 |
Why?
|
Health Services Research | 9 | 2016 | 1808 | 0.620 |
Why?
|
Insurance Benefits | 3 | 2009 | 187 | 0.620 |
Why?
|
Drug Costs | 6 | 2022 | 1183 | 0.610 |
Why?
|
Quality Improvement | 10 | 2019 | 3801 | 0.610 |
Why?
|
Contract Services | 3 | 2013 | 89 | 0.580 |
Why?
|
Health Policy | 9 | 2024 | 2682 | 0.580 |
Why?
|
Hospitalization | 10 | 2023 | 10708 | 0.560 |
Why?
|
Choice Behavior | 5 | 2015 | 825 | 0.550 |
Why?
|
Insurance | 1 | 2018 | 113 | 0.540 |
Why?
|
State Health Plans | 4 | 2018 | 219 | 0.530 |
Why?
|
Contracts | 2 | 2015 | 60 | 0.530 |
Why?
|
Financing, Government | 5 | 2013 | 472 | 0.520 |
Why?
|
Massachusetts | 18 | 2019 | 8835 | 0.520 |
Why?
|
Insurance Claim Review | 9 | 2020 | 741 | 0.520 |
Why?
|
Insurance, Medigap | 2 | 2013 | 20 | 0.510 |
Why?
|
Health Services Accessibility | 7 | 2024 | 5430 | 0.510 |
Why?
|
Chronic Disease | 10 | 2024 | 9310 | 0.500 |
Why?
|
Physician Incentive Plans | 5 | 2018 | 164 | 0.470 |
Why?
|
Competitive Bidding | 1 | 2013 | 16 | 0.460 |
Why?
|
Data Collection | 5 | 2018 | 3316 | 0.460 |
Why?
|
Taxes | 4 | 2019 | 221 | 0.460 |
Why?
|
Anniversaries and Special Events | 1 | 2015 | 95 | 0.450 |
Why?
|
Diabetes Mellitus | 9 | 2021 | 5838 | 0.440 |
Why?
|
Aged | 61 | 2024 | 169092 | 0.430 |
Why?
|
Salaries and Fringe Benefits | 2 | 2014 | 256 | 0.420 |
Why?
|
Formularies as Topic | 1 | 2013 | 94 | 0.410 |
Why?
|
Economic Recession | 1 | 2013 | 79 | 0.400 |
Why?
|
Patient Preference | 2 | 2021 | 925 | 0.400 |
Why?
|
Economics | 1 | 2013 | 141 | 0.400 |
Why?
|
Rate Setting and Review | 1 | 2011 | 41 | 0.400 |
Why?
|
Prescription Drugs | 4 | 2017 | 631 | 0.400 |
Why?
|
Competitive Behavior | 1 | 2012 | 78 | 0.390 |
Why?
|
Fees, Medical | 1 | 2011 | 111 | 0.380 |
Why?
|
Pharmaceutical Preparations | 3 | 2022 | 1086 | 0.380 |
Why?
|
Referral and Consultation | 4 | 2021 | 3599 | 0.370 |
Why?
|
Comparative Effectiveness Research | 2 | 2014 | 708 | 0.370 |
Why?
|
Ambulatory Care | 5 | 2020 | 2768 | 0.370 |
Why?
|
Diagnosis-Related Groups | 2 | 2023 | 448 | 0.360 |
Why?
|
Medicare Part B | 1 | 2011 | 117 | 0.360 |
Why?
|
Female | 88 | 2024 | 392203 | 0.360 |
Why?
|
Male | 83 | 2024 | 360402 | 0.360 |
Why?
|
Capitation Fee | 1 | 2010 | 115 | 0.350 |
Why?
|
Income | 9 | 2017 | 1870 | 0.350 |
Why?
|
Insurance Pools | 2 | 2006 | 13 | 0.340 |
Why?
|
Fees and Charges | 4 | 2015 | 192 | 0.330 |
Why?
|
Program Evaluation | 6 | 2016 | 2486 | 0.330 |
Why?
|
Periodicals as Topic | 2 | 2015 | 1463 | 0.330 |
Why?
|
Drug Prescriptions | 3 | 2019 | 1669 | 0.320 |
Why?
|
Hospital-Physician Joint Ventures | 2 | 2020 | 30 | 0.300 |
Why?
|
Disease Management | 4 | 2008 | 2506 | 0.300 |
Why?
|
Social Welfare | 1 | 2009 | 87 | 0.300 |
Why?
|
Specialization | 1 | 2013 | 778 | 0.300 |
Why?
|
Inflation, Economic | 2 | 2024 | 30 | 0.290 |
Why?
|
Geography | 1 | 2010 | 652 | 0.290 |
Why?
|
Primary Health Care | 7 | 2021 | 4677 | 0.290 |
Why?
|
Medical Savings Accounts | 1 | 2007 | 34 | 0.290 |
Why?
|
Office Visits | 3 | 2018 | 593 | 0.280 |
Why?
|
Fees, Pharmaceutical | 3 | 2014 | 66 | 0.280 |
Why?
|
Health Plan Implementation | 1 | 2010 | 335 | 0.270 |
Why?
|
Patient-Centered Care | 1 | 2017 | 1419 | 0.270 |
Why?
|
Patient Acceptance of Health Care | 7 | 2018 | 3196 | 0.270 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2019 | 12143 | 0.270 |
Why?
|
Episode of Care | 4 | 2022 | 127 | 0.270 |
Why?
|
Cross-Sectional Studies | 13 | 2024 | 26065 | 0.270 |
Why?
|
Decision Making, Organizational | 2 | 2004 | 136 | 0.270 |
Why?
|
Home Care Services | 3 | 2009 | 648 | 0.270 |
Why?
|
Cost Allocation | 2 | 2021 | 49 | 0.260 |
Why?
|
Morals | 1 | 2009 | 289 | 0.260 |
Why?
|
Middle Aged | 45 | 2021 | 220603 | 0.260 |
Why?
|
Nursing Homes | 4 | 2014 | 1083 | 0.250 |
Why?
|
Evidence-Based Practice | 1 | 2010 | 494 | 0.250 |
Why?
|
Politics | 3 | 2018 | 813 | 0.250 |
Why?
|
Uncompensated Care | 1 | 2005 | 37 | 0.250 |
Why?
|
Adult | 43 | 2023 | 220995 | 0.240 |
Why?
|
Risk Sharing, Financial | 1 | 2005 | 47 | 0.240 |
Why?
|
Health Services Misuse | 3 | 2016 | 244 | 0.240 |
Why?
|
Risk Adjustment | 4 | 2019 | 600 | 0.240 |
Why?
|
Drugs, Generic | 3 | 2019 | 448 | 0.230 |
Why?
|
Motivation | 3 | 2021 | 2003 | 0.230 |
Why?
|
Maryland | 3 | 2018 | 277 | 0.220 |
Why?
|
Actuarial Analysis | 1 | 2003 | 372 | 0.220 |
Why?
|
Clinical Coding | 1 | 2024 | 181 | 0.210 |
Why?
|
Adolescent | 26 | 2021 | 88247 | 0.210 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2019 | 3245 | 0.210 |
Why?
|
Young Adult | 20 | 2021 | 59191 | 0.210 |
Why?
|
Privatization | 1 | 2022 | 41 | 0.200 |
Why?
|
Policy Making | 3 | 2022 | 541 | 0.200 |
Why?
|
Pandemics | 2 | 2022 | 8652 | 0.200 |
Why?
|
Cost-Benefit Analysis | 11 | 2016 | 5493 | 0.190 |
Why?
|
Homes for the Aged | 2 | 2014 | 273 | 0.190 |
Why?
|
Health Status Disparities | 2 | 2016 | 1846 | 0.190 |
Why?
|
Life Expectancy | 2 | 2020 | 1242 | 0.190 |
Why?
|
Matched-Pair Analysis | 2 | 2019 | 284 | 0.190 |
Why?
|
Hospitals, Private | 1 | 2021 | 63 | 0.190 |
Why?
|
Insurance Selection Bias | 2 | 2018 | 69 | 0.190 |
Why?
|
Organizational Case Studies | 2 | 2012 | 301 | 0.180 |
Why?
|
Health Status | 3 | 2016 | 4076 | 0.180 |
Why?
|
Confidence Intervals | 2 | 2021 | 2925 | 0.180 |
Why?
|
Health Care Surveys | 8 | 2020 | 2422 | 0.180 |
Why?
|
Pharmacies | 1 | 2022 | 167 | 0.180 |
Why?
|
Patient Compliance | 2 | 2008 | 2688 | 0.180 |
Why?
|
Disclosure | 2 | 2017 | 747 | 0.180 |
Why?
|
Anticholesteremic Agents | 1 | 2008 | 967 | 0.180 |
Why?
|
California | 6 | 2019 | 1431 | 0.180 |
Why?
|
Preferred Provider Organizations | 2 | 2013 | 37 | 0.180 |
Why?
|
Retirement | 1 | 2021 | 197 | 0.170 |
Why?
|
Cardiology Service, Hospital | 2 | 2015 | 239 | 0.170 |
Why?
|
Health Services for the Aged | 4 | 2021 | 258 | 0.170 |
Why?
|
Negotiating | 2 | 2021 | 150 | 0.170 |
Why?
|
Hospital Administration | 1 | 2023 | 353 | 0.160 |
Why?
|
Quality Control | 3 | 2015 | 831 | 0.160 |
Why?
|
Forecasting | 4 | 2015 | 2924 | 0.160 |
Why?
|
Insurance, Pharmaceutical Services | 2 | 2014 | 348 | 0.160 |
Why?
|
Sex Factors | 5 | 2021 | 10549 | 0.160 |
Why?
|
Aged, 80 and over | 21 | 2024 | 58919 | 0.150 |
Why?
|
Attitude to Health | 2 | 2005 | 2025 | 0.150 |
Why?
|
Managed Competition | 2 | 2016 | 32 | 0.150 |
Why?
|
Disabled Persons | 2 | 2005 | 1226 | 0.150 |
Why?
|
Child Health Services | 3 | 2013 | 644 | 0.140 |
Why?
|
Ownership | 1 | 2020 | 339 | 0.140 |
Why?
|
Provider-Sponsored Organizations | 1 | 2016 | 12 | 0.140 |
Why?
|
Linear Models | 8 | 2021 | 5866 | 0.140 |
Why?
|
Oregon | 1 | 2017 | 147 | 0.140 |
Why?
|
Medical Oncology | 2 | 2019 | 2317 | 0.140 |
Why?
|
Models, Theoretical | 1 | 2009 | 3567 | 0.140 |
Why?
|
Socioeconomic Factors | 5 | 2019 | 7805 | 0.140 |
Why?
|
Washington | 1 | 2017 | 315 | 0.130 |
Why?
|
Government Regulation | 1 | 2020 | 524 | 0.130 |
Why?
|
Organizational Innovation | 2 | 2011 | 537 | 0.130 |
Why?
|
Perinatal Care | 1 | 2018 | 244 | 0.130 |
Why?
|
Empirical Research | 2 | 2013 | 120 | 0.130 |
Why?
|
Medically Uninsured | 4 | 2019 | 835 | 0.120 |
Why?
|
Databases, Factual | 4 | 2019 | 7963 | 0.120 |
Why?
|
Legislation, Drug | 1 | 2017 | 214 | 0.120 |
Why?
|
Age Factors | 5 | 2021 | 18381 | 0.120 |
Why?
|
Tobacco Use Cessation | 1 | 2016 | 94 | 0.120 |
Why?
|
Subacute Care | 1 | 2017 | 179 | 0.120 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2015 | 148 | 0.120 |
Why?
|
Access to Information | 1 | 2017 | 316 | 0.120 |
Why?
|
Patient Readmission | 3 | 2023 | 3269 | 0.110 |
Why?
|
Coronary Artery Bypass | 2 | 2007 | 2188 | 0.110 |
Why?
|
Antidepressive Agents | 2 | 2018 | 2896 | 0.110 |
Why?
|
Eligibility Determination | 3 | 2013 | 421 | 0.110 |
Why?
|
Hospital Charges | 1 | 2015 | 350 | 0.110 |
Why?
|
Employee Incentive Plans | 1 | 2013 | 15 | 0.110 |
Why?
|
Health Care Rationing | 2 | 2010 | 436 | 0.110 |
Why?
|
Cohort Studies | 8 | 2021 | 41464 | 0.110 |
Why?
|
Organizational Policy | 2 | 2021 | 432 | 0.110 |
Why?
|
Patient Satisfaction | 2 | 2016 | 3451 | 0.110 |
Why?
|
Cholinesterase Inhibitors | 1 | 2014 | 242 | 0.100 |
Why?
|
Rural Population | 1 | 2023 | 2277 | 0.100 |
Why?
|
Patient Participation | 1 | 2021 | 1443 | 0.100 |
Why?
|
Gross Domestic Product | 1 | 2012 | 77 | 0.100 |
Why?
|
Mammography | 3 | 2016 | 2430 | 0.100 |
Why?
|
Emergency Service, Hospital | 3 | 2017 | 7873 | 0.100 |
Why?
|
Metformin | 2 | 2018 | 906 | 0.100 |
Why?
|
Residence Characteristics | 4 | 2018 | 2092 | 0.100 |
Why?
|
Contraceptive Agents, Female | 1 | 2013 | 118 | 0.100 |
Why?
|
Regression Analysis | 4 | 2011 | 6339 | 0.100 |
Why?
|
Social Values | 1 | 2012 | 225 | 0.090 |
Why?
|
Preventive Medicine | 1 | 2013 | 245 | 0.090 |
Why?
|
Drug Therapy | 1 | 2014 | 503 | 0.090 |
Why?
|
Neoplasms | 5 | 2021 | 22131 | 0.090 |
Why?
|
Drug Resistance, Microbial | 1 | 2014 | 825 | 0.090 |
Why?
|
Physician-Patient Relations | 1 | 2004 | 3239 | 0.090 |
Why?
|
Models, Econometric | 4 | 2005 | 215 | 0.090 |
Why?
|
Relative Value Scales | 1 | 2010 | 84 | 0.090 |
Why?
|
Hospital-Physician Relations | 1 | 2010 | 17 | 0.090 |
Why?
|
Utilization Review | 2 | 2013 | 382 | 0.090 |
Why?
|
Kidney Failure, Chronic | 2 | 2018 | 2474 | 0.080 |
Why?
|
Drug Therapy, Combination | 2 | 2018 | 6305 | 0.080 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2024 | 3204 | 0.080 |
Why?
|
Contraception | 1 | 2013 | 347 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2575 | 0.080 |
Why?
|
Federal Government | 2 | 2012 | 267 | 0.080 |
Why?
|
Patients | 1 | 2016 | 906 | 0.080 |
Why?
|
Reference Values | 1 | 2016 | 4919 | 0.080 |
Why?
|
Medical Assistance | 1 | 2010 | 108 | 0.080 |
Why?
|
Arkansas | 2 | 2019 | 59 | 0.080 |
Why?
|
Retrospective Studies | 9 | 2019 | 80583 | 0.080 |
Why?
|
Preventive Health Services | 1 | 2013 | 566 | 0.080 |
Why?
|
Early Detection of Cancer | 3 | 2022 | 3196 | 0.080 |
Why?
|
State Government | 1 | 2011 | 384 | 0.080 |
Why?
|
Risk Management | 2 | 2017 | 557 | 0.080 |
Why?
|
Propensity Score | 2 | 2013 | 1912 | 0.080 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2012 | 857 | 0.080 |
Why?
|
Terminal Care | 2 | 2018 | 1755 | 0.080 |
Why?
|
Radiation Oncology | 1 | 2014 | 563 | 0.070 |
Why?
|
Demography | 1 | 2013 | 1643 | 0.070 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2014 | 801 | 0.070 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8516 | 0.070 |
Why?
|
Models, Statistical | 5 | 2018 | 5074 | 0.070 |
Why?
|
Cardiac Care Facilities | 1 | 2007 | 34 | 0.070 |
Why?
|
Models, Organizational | 1 | 2010 | 544 | 0.070 |
Why?
|
Alcoholism | 1 | 2018 | 1972 | 0.070 |
Why?
|
National Health Insurance, United States | 1 | 2007 | 100 | 0.070 |
Why?
|
Annual Reports as Topic | 2 | 2016 | 36 | 0.070 |
Why?
|
Databases as Topic | 1 | 2008 | 473 | 0.070 |
Why?
|
Inpatients | 1 | 2018 | 2545 | 0.070 |
Why?
|
Coronary Artery Disease | 2 | 2024 | 6403 | 0.070 |
Why?
|
Drug Discovery | 1 | 2014 | 1051 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10754 | 0.060 |
Why?
|
Planning Techniques | 1 | 2006 | 82 | 0.060 |
Why?
|
Information Systems | 1 | 2008 | 396 | 0.060 |
Why?
|
Multivariate Analysis | 2 | 2012 | 12043 | 0.060 |
Why?
|
Hypercholesterolemia | 1 | 2012 | 1141 | 0.060 |
Why?
|
Organizational Culture | 2 | 2010 | 509 | 0.060 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2013 | 940 | 0.060 |
Why?
|
Telemedicine | 1 | 2022 | 3051 | 0.060 |
Why?
|
Case Management | 2 | 2003 | 272 | 0.060 |
Why?
|
Electrocardiography | 1 | 2018 | 6346 | 0.060 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2019 | 3415 | 0.060 |
Why?
|
Population Dynamics | 1 | 2006 | 306 | 0.060 |
Why?
|
Family Characteristics | 2 | 2006 | 992 | 0.060 |
Why?
|
Cardiology | 1 | 2015 | 1656 | 0.060 |
Why?
|
Decision Trees | 2 | 2005 | 504 | 0.060 |
Why?
|
Mental Health Services | 1 | 2015 | 1717 | 0.060 |
Why?
|
Patient Discharge | 1 | 2017 | 3442 | 0.060 |
Why?
|
Nebulizers and Vaporizers | 1 | 2024 | 139 | 0.060 |
Why?
|
Organizational Objectives | 1 | 2006 | 426 | 0.060 |
Why?
|
SEER Program | 2 | 2021 | 1450 | 0.060 |
Why?
|
Heart Failure | 1 | 2008 | 11670 | 0.060 |
Why?
|
Comorbidity | 3 | 2019 | 10507 | 0.060 |
Why?
|
Medicare Assignment | 2 | 2013 | 9 | 0.060 |
Why?
|
Caregivers | 2 | 2009 | 2241 | 0.050 |
Why?
|
Time Factors | 3 | 2021 | 39908 | 0.050 |
Why?
|
Medication Therapy Management | 1 | 2024 | 130 | 0.050 |
Why?
|
Frail Elderly | 2 | 2013 | 765 | 0.050 |
Why?
|
Michigan | 4 | 2007 | 339 | 0.050 |
Why?
|
Computer Simulation | 1 | 2016 | 6233 | 0.050 |
Why?
|
Time and Motion Studies | 1 | 2003 | 143 | 0.050 |
Why?
|
Myocardial Revascularization | 1 | 2007 | 790 | 0.050 |
Why?
|
Program Development | 2 | 2007 | 1293 | 0.050 |
Why?
|
Opioid-Related Disorders | 1 | 2018 | 2164 | 0.050 |
Why?
|
Hospice Care | 1 | 2010 | 677 | 0.050 |
Why?
|
Product Line Management | 1 | 2002 | 2 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 3805 | 0.050 |
Why?
|
Insurance, Hospitalization | 1 | 2002 | 30 | 0.050 |
Why?
|
Logistic Models | 3 | 2018 | 13248 | 0.050 |
Why?
|
Drug Approval | 2 | 2014 | 812 | 0.050 |
Why?
|
Receptor, erbB-2 | 1 | 2012 | 2553 | 0.050 |
Why?
|
Stomach Ulcer | 1 | 2002 | 122 | 0.050 |
Why?
|
Neuraminidase | 1 | 2002 | 195 | 0.050 |
Why?
|
Decision Making | 2 | 2007 | 3919 | 0.050 |
Why?
|
Lipid Regulating Agents | 1 | 2021 | 21 | 0.050 |
Why?
|
Quality-Adjusted Life Years | 2 | 2005 | 1723 | 0.050 |
Why?
|
Administration, Inhalation | 1 | 2024 | 1156 | 0.050 |
Why?
|
Health Behavior | 1 | 2013 | 2643 | 0.050 |
Why?
|
Positive-Pressure Respiration | 1 | 2005 | 638 | 0.050 |
Why?
|
Marketing of Health Services | 1 | 2002 | 150 | 0.050 |
Why?
|
Antipsychotic Agents | 1 | 2014 | 3067 | 0.050 |
Why?
|
Bronchodilator Agents | 1 | 2024 | 512 | 0.050 |
Why?
|
Health Promotion | 1 | 2013 | 2206 | 0.050 |
Why?
|
Age Distribution | 1 | 2006 | 2872 | 0.050 |
Why?
|
Government Programs | 1 | 2023 | 278 | 0.040 |
Why?
|
Marketing | 1 | 2022 | 220 | 0.040 |
Why?
|
Information Services | 1 | 2002 | 236 | 0.040 |
Why?
|
Pediatrics | 1 | 2015 | 3589 | 0.040 |
Why?
|
Depressive Disorder, Major | 1 | 2018 | 4764 | 0.040 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2024 | 324 | 0.040 |
Why?
|
Critical Care | 1 | 2013 | 2691 | 0.040 |
Why?
|
Substance-Related Disorders | 1 | 2016 | 4416 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2022 | 11107 | 0.040 |
Why?
|
Reminder Systems | 1 | 2003 | 386 | 0.040 |
Why?
|
Treatment Refusal | 1 | 2003 | 429 | 0.040 |
Why?
|
Clinical Competence | 1 | 2015 | 4790 | 0.040 |
Why?
|
Infant, Newborn | 4 | 2016 | 26183 | 0.040 |
Why?
|
Long-Term Care | 1 | 2003 | 631 | 0.040 |
Why?
|
Cardiovascular Diseases | 3 | 2021 | 15498 | 0.040 |
Why?
|
Disability Evaluation | 2 | 2017 | 1835 | 0.040 |
Why?
|
Longitudinal Studies | 2 | 2012 | 14599 | 0.040 |
Why?
|
Attitude of Health Personnel | 1 | 2011 | 3882 | 0.040 |
Why?
|
Infant | 4 | 2016 | 36157 | 0.040 |
Why?
|
Mass Screening | 2 | 2022 | 5425 | 0.030 |
Why?
|
Employment | 1 | 2003 | 1113 | 0.030 |
Why?
|
Cholesterol, LDL | 2 | 2019 | 2378 | 0.030 |
Why?
|
Social Class | 1 | 2006 | 1993 | 0.030 |
Why?
|
Respiratory Insufficiency | 1 | 2005 | 1230 | 0.030 |
Why?
|
Insurance Claim Reporting | 1 | 2017 | 165 | 0.030 |
Why?
|
Child, Preschool | 4 | 2016 | 42193 | 0.030 |
Why?
|
Length of Stay | 1 | 2010 | 6418 | 0.030 |
Why?
|
Cost of Illness | 2 | 2004 | 1937 | 0.030 |
Why?
|
Censuses | 1 | 2017 | 198 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2013 | 22153 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2012 | 10203 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2014 | 7403 | 0.030 |
Why?
|
Diabetes Complications | 1 | 2002 | 1315 | 0.030 |
Why?
|
Decision Support Techniques | 2 | 2002 | 1999 | 0.030 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2016 | 219 | 0.030 |
Why?
|
Workload | 1 | 2020 | 844 | 0.030 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2005 | 1462 | 0.030 |
Why?
|
Diabetic Retinopathy | 1 | 2003 | 1274 | 0.030 |
Why?
|
Antitrust Laws | 1 | 2013 | 8 | 0.030 |
Why?
|
Renal Dialysis | 1 | 2003 | 1795 | 0.030 |
Why?
|
Breast Neoplasms | 3 | 2016 | 20988 | 0.030 |
Why?
|
Bankruptcy | 1 | 2013 | 26 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2016 | 13635 | 0.030 |
Why?
|
Child | 5 | 2016 | 80089 | 0.030 |
Why?
|
Missouri | 1 | 2013 | 115 | 0.030 |
Why?
|
Prostate-Specific Antigen | 1 | 2022 | 2465 | 0.030 |
Why?
|
Physician Self-Referral | 1 | 2012 | 18 | 0.030 |
Why?
|
Random Allocation | 1 | 2017 | 2392 | 0.030 |
Why?
|
Coronary Angiography | 1 | 2024 | 4470 | 0.030 |
Why?
|
Delusions | 1 | 2014 | 298 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2002 | 2270 | 0.020 |
Why?
|
Hallucinations | 1 | 2014 | 366 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2002 | 3705 | 0.020 |
Why?
|
Inappropriate Prescribing | 1 | 2014 | 212 | 0.020 |
Why?
|
Influenza, Human | 1 | 2002 | 1521 | 0.020 |
Why?
|
Critical Pathways | 1 | 2014 | 474 | 0.020 |
Why?
|
Tobacco Use Disorder | 1 | 2016 | 703 | 0.020 |
Why?
|
Markov Chains | 2 | 2005 | 965 | 0.020 |
Why?
|
Information Storage and Retrieval | 1 | 2015 | 819 | 0.020 |
Why?
|
Software | 1 | 2024 | 4432 | 0.020 |
Why?
|
Ambulatory Care Facilities | 1 | 2016 | 934 | 0.020 |
Why?
|
Cause of Death | 1 | 2020 | 3683 | 0.020 |
Why?
|
Research Support as Topic | 1 | 2014 | 697 | 0.020 |
Why?
|
Aggression | 1 | 2014 | 750 | 0.020 |
Why?
|
National Health Programs | 1 | 2013 | 440 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2014 | 1333 | 0.020 |
Why?
|
Counseling | 1 | 2016 | 1538 | 0.020 |
Why?
|
Outpatients | 1 | 2016 | 1596 | 0.020 |
Why?
|
Health Status Indicators | 1 | 2013 | 970 | 0.020 |
Why?
|
Algorithms | 2 | 2021 | 14024 | 0.020 |
Why?
|
Health Literacy | 1 | 2013 | 443 | 0.020 |
Why?
|
Glyburide | 1 | 2008 | 116 | 0.020 |
Why?
|
Confidentiality | 1 | 2010 | 608 | 0.020 |
Why?
|
Health Education | 1 | 2013 | 1049 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2014 | 7390 | 0.020 |
Why?
|
Information Dissemination | 1 | 2014 | 1126 | 0.020 |
Why?
|
Continuity of Patient Care | 1 | 2013 | 1067 | 0.020 |
Why?
|
Odds Ratio | 1 | 2018 | 9644 | 0.020 |
Why?
|
New York | 1 | 2008 | 875 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 2010 | 770 | 0.020 |
Why?
|
Nutrition Surveys | 1 | 2012 | 1725 | 0.020 |
Why?
|
Qualitative Research | 1 | 2015 | 3017 | 0.020 |
Why?
|
Women's Health Services | 1 | 2005 | 88 | 0.010 |
Why?
|
Risk Factors | 4 | 2019 | 74128 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2014 | 6016 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2014 | 2218 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2010 | 2358 | 0.010 |
Why?
|
Women's Health | 1 | 2013 | 2066 | 0.010 |
Why?
|
Social Marketing | 1 | 2003 | 52 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2020 | 4810 | 0.010 |
Why?
|
Hospitals, General | 1 | 2007 | 798 | 0.010 |
Why?
|
Myocardial Ischemia | 1 | 2013 | 2110 | 0.010 |
Why?
|
Immunization Programs | 1 | 2005 | 267 | 0.010 |
Why?
|
Drug Combinations | 1 | 2008 | 2048 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2014 | 7050 | 0.010 |
Why?
|
Critical Illness | 1 | 2013 | 2709 | 0.010 |
Why?
|
Cognition Disorders | 1 | 2014 | 3979 | 0.010 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2007 | 1723 | 0.010 |
Why?
|
Heart Diseases | 1 | 2013 | 2778 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2008 | 4845 | 0.010 |
Why?
|
Survival Analysis | 1 | 2012 | 10072 | 0.010 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2003 | 495 | 0.010 |
Why?
|
Smoking | 1 | 2016 | 9054 | 0.010 |
Why?
|
Health Services Needs and Demand | 1 | 2007 | 1400 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 14649 | 0.010 |
Why?
|
Biomedical Research | 1 | 2014 | 3426 | 0.010 |
Why?
|
Drug Industry | 1 | 2003 | 788 | 0.010 |
Why?
|
Pregnancy | 1 | 2018 | 29869 | 0.010 |
Why?
|
Quality of Life | 2 | 2010 | 13359 | 0.010 |
Why?
|
Geriatric Assessment | 1 | 2003 | 1411 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2005 | 2689 | 0.010 |
Why?
|
United States Food and Drug Administration | 1 | 2003 | 1661 | 0.010 |
Why?
|
Depression | 1 | 2014 | 8132 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2005 | 3680 | 0.010 |
Why?
|
Health Surveys | 1 | 2002 | 4036 | 0.010 |
Why?
|
Risk Assessment | 2 | 2003 | 23974 | 0.010 |
Why?
|
Risk | 1 | 2003 | 9603 | 0.010 |
Why?
|
Hypertension | 1 | 2010 | 8532 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2005 | 7995 | 0.010 |
Why?
|
Insulin | 1 | 2002 | 6593 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 2002 | 12966 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 2008 | 39062 | 0.000 |
Why?
|
Predictive Value of Tests | 1 | 2002 | 15250 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2002 | 64572 | 0.000 |
Why?
|